HeraMED

(ASX) HMD

Current Price$0.05

Market Cap$56.59M

Since IPO (2018)-74%

5 Year-69%

1 Year+206%

1 Month-2%

HeraMED Financials at a Glance

Market Cap

$56.59M

Revenue (TTM)

$428.64K

Net Income (TTM)

$6.29M

EPS (TTM)

$-0.00

P/E Ratio

-11.40

Dividend

$0.00

Beta (Volatility)

-0.19 (Low)

Dividend

$0.00

Beta (Volatility)

-0.19 (Low)

Price

$0.05

Volume

2,088,968

Open

$0.05

Price

$0.05

Volume

2,088,968

Open

$0.05

Previous Close

$0.05

Daily Range

$0.05 - $0.05

52-Week Range

$0.01 - $0.06

Dividend

$0.00

Beta (Volatility)

-0.19 (Low)

Price

$0.05

Volume

2,088,968

Open

$0.05

Previous Close

$0.05

Daily Range

$0.05 - $0.05

52-Week Range

$0.01 - $0.06

HMD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About HeraMED

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

17,000

CEO

Anoushka Gungadin, MBA

Website

www.hera-med.com

Headquarters

Netanya, 4250604, IL

HMD Financials

Key Financial Metrics (TTM)

Gross Margin

72%

Operating Margin

-13%

Net Income Margin

-14%

Return on Equity

-223%

Return on Capital

-4%

Return on Assets

-3%

Earnings Yield

-8.77%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$56.59M

Shares Outstanding

1.15B

Volume

2.09M

Avg. Volume

1.65M

Financials (TTM)

Gross Profit

$99.78K

Operating Income

$2.66M

EBITDA

$2.56M

Operating Cash Flow

$2.44M

Capital Expenditure

$3.34

Free Cash Flow

$2.44M

Cash & ST Invst.

$914.65K

Total Debt

$282.39K

HeraMED Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$102.69K

-51.2%

Gross Profit

$97.36K

+161.6%

Gross Margin

94.81%

N/A

Market Cap

$56.59M

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$1.25M

+48.2%

EBITDA

$1.10M

+55.5%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$632.27K

+23.0%

Accounts Receivable

$27.36K

-92.0%

Inventory

$0.00

-100.0%

Long Term Debt

$237.46K

N/A

Short Term Debt

$44.93K

-78.5%

Return on Assets

-2.75%

N/A

Return on Invested Capital

-3.85%

N/A

Free Cash Flow

$1.15M

+48.7%

Operating Cash Flow

$1.15M

+48.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RHY.AXRhythm Biosciences Limited

RHY.AXRhythm Biosciences Limited$0.14+3.70%

EYE.AXNova Eye Medical Limited

EYE.AXNova Eye Medical Limited$0.13-3.85%

BDX.AXBCAL Diagnostics Limited

BDX.AXBCAL Diagnostics Limited$0.08+0.00%

NOX.AXNoxopharm Limited

NOX.AXNoxopharm Limited$0.07+7.14%

AT1.AXAtomo Diagnostics Limited

AT1.AXAtomo Diagnostics Limited$0.02+0.00%

IDT.AXIDT Australia Limited

IDT.AXIDT Australia Limited$0.04+0.00%

NTI.AXNeurotech International Limited

NTI.AXNeurotech International Limited$0.01+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$99.62+0.05%

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

TSLATesla

TSLATesla$390.82+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About HMD

What is the current price of HeraMED?

HeraMED is trading at A$0.05 per share.

What is the 52-week range for HeraMED?

Over the past 52 weeks, HeraMED has traded between A$0.01 and A$0.06.

How much debt does HeraMED have?

As of the most recent reporting period, HeraMED reported total debt of N/A.

How much cash does HeraMED have on hand?

HeraMED reported $1.37M in cash and cash equivalents in its most recent financial results.

What is HeraMED’s dividend yield?

HeraMED does not currently have a dividend yield.

HeraMED

HeraMED Financials at a Glance

HMD News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About HeraMED

HMD Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

HeraMED Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About HMD

What is the current price of HeraMED?

What is the 52-week range for HeraMED?

How much debt does HeraMED have?

How much cash does HeraMED have on hand?

What is HeraMED’s dividend yield?

Premium Investing Services